Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients every year.
How Big is The Pain Management Therapeutics Market?
The pain management therapeutics market is expected to be around US$ 95.20 Billion by 2028; Growing at a CAGR of more than 3.5% in the given forecast period.
The major driving factors of pain management therapeutics market are as follows:
Approving health care reforms and regulatory scenario
Increasing approval of pain management therapeutics between end users
Increasing in geriatric population with high risk of different diseases
Growing frequency of chronic pain disorders
The restraining factors of pain management therapeutics market are as follows:
Enduring pain relief from medical devices, alternative therapies and surgical procedures
Prescription drug exploitation
Exclusive rights expiry of entry of generics and key drugs
The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeutics market covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for pain management therapeutics and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for pain management therapeutics.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for pain management therapeutics with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide buyers with a snapshot of the industry’s most influential players.
The Pain management therapeutics Market has been segmented as below:
By Therapeutics Analysis
Antimigraine agents
Non steroidal anti inflammatory drugs
Anesthetics
Antidepressants
Anticonvulsants
Opioids
Tramadol
Hydrocodones
Oxycodaones
Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine)
Other non narcotic analgesic
By Indication Analysis
Cancer pain
Post operative pain
Migraine
Arthritic pain
Chronic back pain
Fibromyalgia
Neuropathic pain
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all pain management therapeutics market globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of pain management therapeutics data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
1. INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2. Executive Summary
2.1. Pain Management Therapeutics Market, 2022–2027: Market Snapshot
2.2. Global Pain Management Therapeutics Market Share, by Geography,2022–2027
2.3. Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2022
2.4. Global Pain Management Therapeutics Market Revenue, By Indication, (US$ Mn), 2022
3. Global Pain Management Therapeutics Market – Industry Analysis
3.1. Market Dynamics
3.1.1. Market Drivers
3.1.1.1. Increase in incidence of chronic pain disorders
3.1.1.2. Rise in geriatric population with high risk of various diseases
3.1.1.3. Growing adoption of pain management therapeutics among end-users
3.1.1.4. Favorable regulatory scenario and health care reforms
3.1.2. Restraints
3.1.2.1. Patent expiry of key drugs and entry of generics
3.1.2.2. Prescription drug abuse
3.1.2.3. Long term pain relief from surgical procedures, alternative therapies, and medical devices
3.1.3. Opportunities
3.1.3.1. Asia Pacific holds immense potential for pain management therapeutics
3.1.3.2. Launch of novel molecule combinations and drug delivery techniques
3.2. Market Attractiveness Analysis
3.3. Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2015–2025
3.3.1. Overview
3.3.2. Anticonvulsants
3.3.3. Antidepressants
3.3.4. Anesthetics
3.3.5. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
3.3.6. Opioids
3.3.6.1. Overview
3.3.6.2. Oxycodones
3.3.6.3. Hydrocodones
3.3.6.4. Tramadol
3.3.6.5. Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
3.3.7. Antimigraine Agents
3.3.8. Other Non-narcotic Analgesic
3.4. Global Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2015–2025
3.4.1. Overview
3.4.2. Neuropathic Pain
3.4.3. Fibromyalgia
3.4.4. Arthritic Pain
3.4.5. Chronic Back Pain
3.4.6. Migraine
3.4.7. Post-operative Pain
3.4.8. Cancer Pain
3.5. Market Share Analysis
4. North America Pain Management Therapeutics Market Revenue, (US$ Mn), 2022–2027
4.1. Key Trend Analysis
4.2. North America Pain Management Therapeutics Market by Therapeutic
4.3. North America Pain Management Therapeutics Market by Indication
5. Europe Pain Management Therapeutics Market Revenue, (US$ Mn), 2022–2027
5.1. Key Trend Analysis
5.2. Europe Pain Management Therapeutics Market by Therapeutic
5.3. Europe Pain Management Therapeutics Market by Indication
6. Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn), 2022–2027
6.1. Key Trend Analysis
6.2. Asia Pacific Pain Management Therapeutics Market by Therapeutic
6.3. Asia Pacific Pain Management Therapeutics Market by Indication
7. Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn), 2022–2027
7.1. Key Trend Analysis
7.2. Rest of World Pain Management Therapeutics Market by Therapeutic
7.3. Rest of World Pain Management Therapeutics Market by Indication
8. Country Snippet
8.1. Overview
8.2. U.S. Pain Management Therapeutics Market Revenue, (US$ Mn) 2022–2027
8.3. Canada Pain Management Therapeutics Market Revenue (US$ Mn) 2022–2027
8.4. U.K. Pain Management Therapeutics Market Revenue (US$ Mn) 2022–2027
8.5. Germany Pain Management Therapeutics Market Revenue (US$ Mn) 2022–2027
8.6. China Pain Management Therapeutics Market Revenue (US$ Mn) 2022–2027
8.7. Japan Pain Management Therapeutics Market Revenue (US$ Mn) 2022–2027
8.8. Brazil Pain Management Therapeutics Market Revenue (US$ Mn) 2022–2027
8.9. Mexico Pain Management Therapeutics Market Revenue (US$ Mn) 2022–2027
9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.3. Financial Overview
9.1.4. Business Strategy
9.1.5. Recent Developments
9.2. AstraZeneca
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Financial Overview
9.2.4. Business Strategy
9.2.5. Recent Developments
9.3. Depomed, Inc.
9.3.1. Company Overview
9.3.2. Product Portfolio
9.3.3. Financial Overview
9.3.4. Business Strategy
9.3.5. Recent Developments
9.4. Endo Pharmaceuticals, Inc.
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Financial Overview
9.4.4. Business Strategy
9.4.5. Recent Developments
9.5. GlaxoSmithKline plc
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Financial Overview
9.5.4. Business Strategy
9.5.5. Recent Developments
9.6. Johnson & Johnson
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Financial Overview
9.6.4. Business Strategy
9.6.5. Recent Developments
9.7. Mallinckrodt Pharmaceuticals
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Financial Overview
9.7.4. Business Strategy
9.7.5. Recent Developments
9.8. Merck & Co., Inc.
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Financial Overview
9.8.4. Business Strategy
9.8.5. Recent Developments
9.9. Novartis AG
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Financial Overview
9.9.4. Business Strategy
9.9.5. Recent Developments
9.10. Pfizer, Inc.
9.10.1. Company Overview
9.10.2. Product Portfolio
9.10.3. Financial Overview
9.10.4. Business Strategy
9.10.5. Recent Developments
9.11. Purdue Pharma L.P.
9.11.1. Company Overview
9.11.2. Product Portfolio
9.11.3. Financial Overview
9.11.4. Business Strategy
9.11.5. Recent Developments
9.12. Teva Pharmaceutical Industries Limited
9.12.1. Company Overview
9.12.2. Product Portfolio
9.12.3. Financial Overview
9.12.4. Business Strategy
9.12.5. Recent Developments
The Pain management therapeutics Market has been segmented as below:
By Therapeutics Analysis
Antimigraine agents
Non steroidal anti inflammatory drugs
Anesthetics
Antidepressants
Anticonvulsants
Opioids
Tramadol
Hydrocodones
Oxycodaones
Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine)
Other non narcotic analgesic
By Indication Analysis
Cancer pain
Post operative pain
Migraine
Arthritic pain
Chronic back pain
Fibromyalgia
Neuropathic pain
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
